Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Global Health's management is scheduled to meet with institutional investors, ICICI Prudential AMC Ltd and IIFL Capital Asset Management Limited, on May 27 and May 28, 2026. No unpublished price sensitive information will be shared.
May 22 2026 18:05:46
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Global Health's management is scheduled to meet with institutional investors, ICICI Prudential AMC Ltd and IIFL Capital Asset Management Limited, on May 27 and May 28, 2026. No unpublished price sensitive information will be shared.
May 22 2026 17:59:09
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Global Health has provided a link to the audio recording of its earnings conference call held on May 15, 2026. The call, hosted by ICICI Securities, discussed the company's financial results for Q4 FY26 and the full financial year.
May 15 2026 16:08:32
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Global Health announced strong Q4 FY26 results with total income increasing 25.3% YoY to Rs.11,958 million. Net profit for the quarter grew 39.7% YoY to Rs.1,417 million, driven by robust operational performance and patient volume growth.
May 14 2026 18:43:10
Global Health Limited
Global Health's board has declared a final dividend of Rs.0.50 per equity share for the financial year 2025-26. This dividend is equivalent to 25% of the face value. The record date will be announced closer to the Annual General Meeting date.
May 14 2026 17:05:25
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Change in Management
Global Health announced key leadership changes. Kedar Ashok Apte has been appointed as Chief Marketing & Growth Officer, and Jagdeep Singh as General Counsel and Senior Management Personnel, both effective May 14, 2026. This strengthens the company's strategic leadership.
May 14 2026 17:02:30
Global Health Ltd - 543654 - Board Meeting Outcome for Board Meeting Outcome For Intimation Under Regulation 30 Of SEBI Listing Regulations.
Global Health Limited reported Q4 FY26 consolidated revenue of ₹11,590.47 mn and net profit of ₹1,416.53 mn, up 45% and 40% YoY respectively. The company also recommended a final dividend of ₹0.50 per equity share and appointed two Senior Management Personnel (SMPs).
May 14 2026 16:38:40
Global Health Ltd - 543654 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And Recommendation Of Final Dividend.
Global Health's Board of Directors is scheduled to meet on May 14, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026, and recommending a final dividend.
May 06 2026 15:41:42
Read More